EASL DeepDive: Glucagon in MASH: a next step in “metabolic” drugs tackling liver disease?
| Event title | Event dates | Event venue | Website of the event | Main speciality | Name of the CME provider | Amount of ECMEC® credits |
|---|---|---|---|---|---|---|
| EASL DeepDive: Glucagon in MASH: a next step in “metabolic” drugs tackling liver disease? | 30/10/2024 - 30/10/2024 | Switzerland, Virtual | Website | Gastroenterology | European Association for the Study of the Liver | 1.0 European CME credits (ECMEC®) |
